<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
-------------
Dateof Report (Date of Earliest Event Reported): February 3, 1997
AVATEX CORPORATION
---------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware
---------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-8549 25-1425889
------------------------------ ------------------------
(Commission File Number) (I.R.S. Employer
Identification No.)
5910 North Central Expressway, Suite 1780
Dallas, Texas 75206 75206
--------------------------------------------- --------------
(Address of Principal Executive Offices) (Zip Code)
(214) 365-7450
---------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
FoxMeyer Health Corporation
1220 Senlac Drive, Carrollton, Texas 75006
--------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
<PAGE>
Item 5. Other Events
------ ------------
FoxMeyer Health Corporation ("Fox Health") has
changed its name to Avatex Corporation. The name change was
effected by merging Fox Health with and into one of its
wholly-owned subsidiaries. Shares of the Registrant will
continue to trade on the New York Stock Exchange under the
name "FoxMeyer Health Corporation" and the "FOX" symbol for
an interim period of approximately two-to-three weeks. The
Registrant will announce the effective date for trading
purposes under its new name and trading symbol, "AAV".
On January 13, 1997, the United States Bankruptcy
Court for the District of Delaware, presiding over the
Chapter 11 case of certain of the Registrant's subsidiaries,
including FoxMeyer Corporation and FoxMeyer Drug Company,
entered a Temporary Restraining Order in litigation filed by
the Creditors' Committee against the Registrant. The
Temporary Restraining Order requires, among other things,
that the Creditors' Committee be provided ten days prior
notice of any proposed transfer, sale or other dispositions
or any encumbrance or pledge, of any of the Registrant's
assets that were conveyed to the Registrant on June 19, 1996
by its subsidiary FoxMeyer Corporation or of any of the
Registrant's other assets except in the ordinary course of
business. The Temporary Restraining Order, however, does
not affect the October 1996 sale of FoxMeyer Canada Inc. A
hearing will be held on March 5, 1997 to consider the
Creditor's Committee's motion for a preliminary injunction
seeking the foregoing relief.
Reference is hereby made to the Press Release,
dated February 3, 1997, issued by Fox Health, which is
attached hereto as Exhibit 99.1 and is incorporated herein
by reference.
Item 7. Financial Statements and Exhibits
------- ---------------------------------
(c) Exhibits.
99.1 Press Release, dated February 3, 1997,
issued by FoxMeyer Health Corporation.
<PAGE>
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
AVATEX CORPORATION
(Registrant)
DATE: February 3, 1997 By: /s/ Edward L. Massman
---------------------------
Edward L. Massman
Senior Vice President and
Chief Financial Officer
<PAGE>
<PAGE>
EXHIBIT INDEX
Exhibit No. Description Page No.
----------- ----------- --------
99.1 Press Release, dated February 3, 1997,
issued by FoxMeyer Health Corporation.
<PAGE>
Exhibit 99.1
------------
FOXMEYER HEALTH ANNOUNCES NAME CHANGE TO AVATEX CORPORATION
AND ENTRY OF TEMPORARY RESTRAINING ORDER
DALLAS, TX - FEBRUARY 3, 1997 -- FOXMEYER HEALTH
CORPORATION (NYSE: FOX) today announced that it is
changing its name to Avatex Corporation. Shares of the
Corporation will continue to trade on the New York Stock
Exchange under the FoxMeyer Health name and "FOX" symbol for
an interim period of approximately two-to-three weeks; the
Corporation will announce the effective date for trading
purposes of the new name and its new stock symbol, "AAV".
Existing FoxMeyer Health stock certificates will continue to
be valid and will not have to be exchanged for new
certificates with the Avatex Corporation name. The
Corporation stated that it is changing its name as part of
its agreement to sell substantially all of the assets of its
FoxMeyer Drug Company subsidiary in late 1996.
Separately, FoxMeyer Health announced that on
January 13, 1997, the United States Bankruptcy Court for the
District of Delaware, presiding over the Chapter 11 case of
certain of FoxMeyer Health's subsidiaries, including
FoxMeyer Corporation and FoxMeyer Drug Company, entered a
Temporary Restraining Order in litigation filed by the
Creditors' Committee against FoxMeyer Health. The Order
requires FoxMeyer Health to provide ten days prior notice to
the Committee of any proposed (a) transfer, sale or other
disposition of any assets that were conveyed by its
subsidiary, FoxMeyer Corporation, to FoxMeyer Health on June
19, 1996 or any proceeds from any sale or other disposition
thereof, (b) transfer, sale or other disposition of any of
FoxMeyer Health's other assets except in the ordinary course
of business, or (c) encumbrance or pledge of any of such
assets. The order, however, does not affect the sale of
FoxMeyer Canada Inc., which closed in October 1996. The
Court set a hearing on March 5, 1997 on the Committee's
motion for a preliminary injunction seeking the foregoing
relief.
NYFS05...:\35\64935\0001\2505\FRM1317S.470
